Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration

Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病

基本信息

项目摘要

DESCRIPTION (provided by applicant): Reversal of Diabetes by Pdx1-VP16 and Pax4 Induced Islet Regeneration It has been demonstrated that endocrine pancreas has a potential to regeneration and the process could be facilitated by many factors like Exendin-4. The induction of endogenous beta cell regeneration could revolutionize diabetes therapy. Nonetheless, no robust regeneration-inducing protocol has been determined so far. Key pancreatic transcription factors such as Pdx1 and Pax4 has been demonstrated to reprogram stem cell in favor of endocrine pancreas differentiation. Understanding the factors and mechanisms involved in (-cell regeneration will guide therapeutic efforts to augment (-cell mass in patients with diabetes. Therefore, we hypothesize that in vivo delivery of pancreatic transcription factors (i.e., Pdx1-VP16 and Pax4) into the pancreas of diabetic mice and nonhuman primates will promote islet cell regeneration and restore pancreatic endocrine function. In this study, we will blaze the trail to regeneration through the following approach: 1. To determine the effect of Pdx1-VP16 and Pax4 delivery on blood glucose levels and islet cell regeneration in a diabetic mouse model. 2. To determine the effects of Pdx1-VP16 and Pax4 on promoting islet cell regeneration in a spontaneous diabetic NOD mouse model in settings with and without control of autoimmunity. 3. To examine whether delivery of human Pdx1 by AAV8 vector to the pancreas of non-human primates (NHP) suffering from spontaneous T2DM can reverse hyperglycemia. It is possible that new therapeutic strategies may arise from harnessing pancreatic transcription factors in innovative ways in order to regenerate islets lost to diabetes.
描述(由申请人提供):

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONGQI DQ TANG其他文献

DONGQI DQ TANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONGQI DQ TANG', 18)}}的其他基金

Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration
Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病
  • 批准号:
    8076357
  • 财政年份:
    2008
  • 资助金额:
    $ 10.99万
  • 项目类别:
Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration
Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病
  • 批准号:
    7629599
  • 财政年份:
    2008
  • 资助金额:
    $ 10.99万
  • 项目类别:
Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration
Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病
  • 批准号:
    7826696
  • 财政年份:
    2008
  • 资助金额:
    $ 10.99万
  • 项目类别:
Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration
Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病
  • 批准号:
    7806240
  • 财政年份:
    2008
  • 资助金额:
    $ 10.99万
  • 项目类别:
Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration
Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病
  • 批准号:
    8277060
  • 财政年份:
    2008
  • 资助金额:
    $ 10.99万
  • 项目类别:
Reveresal of Diabetes by Pdx1-VP16 and Pax4-Induced Islet Regeneration
Pdx1-VP16 和 Pax4 诱导的胰岛再生逆转糖尿病
  • 批准号:
    7449051
  • 财政年份:
    2008
  • 资助金额:
    $ 10.99万
  • 项目类别:

相似海外基金

The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Using whole genome sequencing to identify non-coding elements associated with diabetes and related traits across ancestries
使用全基因组测序来识别与糖尿病相关的非编码元件和跨祖先的相关特征
  • 批准号:
    MR/Y003748/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Research Grant
Co-DiRECT Nepal: a community-based diet programme for remission of type 2 diabetes and amelioration of non-communicable disease risks
Co-DiRECT 尼泊尔:旨在缓解 2 型糖尿病和改善非传染性疾病风险的社区饮食计划
  • 批准号:
    MR/Z000513/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Research Grant
SBIR Phase I: Treatment of Type 2 Diabetes through Cryoablation of the Duodenum
SBIR 第一阶段:通过十二指肠冷冻消融治疗 2 型糖尿病
  • 批准号:
    2321818
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Standard Grant
Metal-Organic Framework-Based Gas Sensors: Structural Engineering for Early Diabetes Diagnosis and Monitoring (SEEDDM)
基于金属有机框架的气体传感器:早期糖尿病诊断和监测的结构工程 (SEEDDM)
  • 批准号:
    EP/Y002318/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Research Grant
Understanding the impact of type 1 diabetes and statin use on vascular cells
了解 1 型糖尿病和他汀类药物的使用对血管细胞的影响
  • 批准号:
    MR/Y001028/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Research Grant
Maternal extracellular vesicles as key mediators of fetal growth and offspring cardiometabolic health in pregnancies complicated by type-1 diabetes.
母体细胞外囊泡是妊娠并发 1 型糖尿病时胎儿生长和后代心脏代谢健康的关键介质。
  • 批准号:
    MR/Y003659/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Research Grant
Investigating the blood glucose lowering effect of exogenous ketone ingestion in people with type 2 diabetes
研究外源性酮摄入对 2 型糖尿病患者的降血糖作用
  • 批准号:
    MR/Y008804/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Research Grant
Real-world evidence for decisions in diabetes
糖尿病决策的真实证据
  • 批准号:
    10066570
  • 财政年份:
    2023
  • 资助金额:
    $ 10.99万
  • 项目类别:
    EU-Funded
Identifying research priorities and equitable and integrated policy interventions for diabetes prevention within health care and community settings
确定卫生保健和社区环境中预防糖尿病的研究重点以及公平和综合的政策干预措施
  • 批准号:
    480923
  • 财政年份:
    2023
  • 资助金额:
    $ 10.99万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了